FRAZIER MANAGEMENT LLC
SEATTLE, WA · CIK 1032165 · 13F filing filed 2020-08-04
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityFRAZIER MANAGEMENT, L.L.C. (US)
- Others nearbySeattle, WA
As an employer
US visa salary filings
- Filings FY20251
- Median salary offered$125,000
- Middle half$125,000 – $125,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Associate, Investment AnalystSeattle, WA | 1 | $125,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.
$1.1bn
reported value
+29.1% vs Q1 2020
26positions
86.4%in top 10
2 new
4 added
3 reduced
1 sold out
vs Q1 2020
Holdings, Q2 2020
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $318.8m28.00% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $191.8m16.84% | Reduced -1.5m |
| PASSAGE BIO INC COM | $136.9m12.02% | Unchanged |
| VAXCYTE INC PCVX | $73.0m6.41% | New |
| MIRUM PHARMACEUTICALS INC MIRM | $69.4m6.10% | Unchanged |
| ANAPTYSBIO INC ANAB | $51.7m4.54% | Unchanged |
| TRANSLATE BIO INC COM | $39.1m3.43% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $37.1m3.26% | Unchanged |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $36.0m3.16% | Reduced -437.7k |
| ADVERUM BIOTECHNOLOGIES INC COM | $30.0m2.63% | Added +158.7k |
| ALPINE IMMUNE SCIENCES INC NVLS | $25.0m2.19% | Unchanged |
| TRILLIUM THERAPEUTICS INC TR | $22.3m1.96% | Added +311.2k |
| SYNDAX PHARMACEUTICALS INC SNDX | $19.6m1.72% | Added +329.3k |
| COLLEGIUM PHARMACEUTICAL INC COLL | $16.5m1.45% | Unchanged |
| GRITSTONE BIO INC GRTS | $13.7m1.20% | Unchanged |
| APTINYX INC COM | $13.3m1.17% | Unchanged |
| IVERIC BIO INC OPHT | $12.1m1.06% | New |
| ROCKET PHARMACEUTICALS INC RCKT | $11.1m0.97% | Added +318.0k |
| ALLENA PHARMACEUTICALS ALNA | $5.3m0.46% | Unchanged |
| CIDARA THERAPEUTICS INC COM | $4.8m0.43% | Unchanged |
| NABRIVA THERAPEUTICS PLC NBRV | $2.9m0.25% | Unchanged |
| SIERRA ONCOLOGY INC COM NEW | $2.5m0.22% | Unchanged |
| VTV THERAPEUTICS INC VTVT | $2.4m0.21% | Unchanged |
| ITERUM THERAPEUTICS PLC ITRMF | $1.8m0.16% | Unchanged |
| ENTASIS THERAPEUTICS HLDGS I COM | $1.0m0.09% | Reduced -700.0k |
| BELLICUM PHARMACEUTICALS INC BLCM | $781.0k0.07% | Unchanged |
Sold out since Q1 2020
| Security | Value then |
|---|---|
| MILLENDO THERAPEUTICS INC | $7.4m1.4m shares |